172 related articles for article (PubMed ID: 27296017)
1. Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.
Neřoldová M; Stránecký V; Hodaňová K; Hartmannová H; Piherová L; Přistoupilová A; Mrázová L; Vrablík M; Adámková V; Hubáček JA; Jirsa M; Kmoch S
Pharmacogenomics; 2016 Aug; 17(13):1405-14. PubMed ID: 27296017
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
[TBL] [Abstract][Full Text] [Related]
3. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
Ramakumari N; Indumathi B; Katkam SK; Kutala VK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
[TBL] [Abstract][Full Text] [Related]
4. Statin-induced myopathy SLCO1B1 521T > C is associated with prediabetes, high body mass index and normal lipid profile in Emirati population.
Saber-Ayad M; Manzoor S; El-Serafi A; Mahmoud I; Abusnana S; Sulaiman N
Diabetes Res Clin Pract; 2018 May; 139():272-277. PubMed ID: 29534995
[TBL] [Abstract][Full Text] [Related]
5. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
6. Large copy-number variations in patients with statin-associated myopathy affecting statin myopathy-related loci.
Stránecký V; Neřoldová M; Hodaňová K; Hartmannová H; Piherová L; Zemánková P; Přistoupilová A; Vrablík M; Adámková V; Kmoch S; Jirsa M
Physiol Res; 2016 Dec; 65(6):1005-1011. PubMed ID: 27539103
[TBL] [Abstract][Full Text] [Related]
7. SLCO1B1 variants and statin-induced myopathy.
Vladutiu GD; Isackson PJ
N Engl J Med; 2009 Jan; 360(3):304. PubMed ID: 19144951
[No Abstract] [Full Text] [Related]
8. The genetics of statin-induced myopathy.
Ghatak A; Faheem O; Thompson PD
Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
[TBL] [Abstract][Full Text] [Related]
9. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
[TBL] [Abstract][Full Text] [Related]
10. Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.
Hou Q; Li S; Li L; Li Y; Sun X; Tian H
Medicine (Baltimore); 2015 Sep; 94(37):e1268. PubMed ID: 26376374
[TBL] [Abstract][Full Text] [Related]
11. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
Khine H; Yuet WC; Adams-Huet B; Ahmad Z
Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
[TBL] [Abstract][Full Text] [Related]
12. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
[TBL] [Abstract][Full Text] [Related]
13. SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.
Liu JE; Liu XY; Chen S; Zhang Y; Cai LY; Yang M; Lai WH; Ren B; Zhong SL
Eur J Clin Pharmacol; 2017 Nov; 73(11):1409-1416. PubMed ID: 28812116
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics and adverse drug reactions: the case of statins.
Giorgi MA; Caroli C; Arazi HC; Di Girolamo G
Expert Opin Pharmacother; 2011 Jul; 12(10):1499-509. PubMed ID: 21568825
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.
Danik JS; Chasman DI; MacFadyen JG; Nyberg F; Barratt BJ; Ridker PM
Am Heart J; 2013 Jun; 165(6):1008-14. PubMed ID: 23708174
[TBL] [Abstract][Full Text] [Related]
16. ASSOCIATION OF SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1 GENE POLYMORPHISM WITH RESPONSE TO ATORVASTATIN AND ASSOCIATED MYOPATHY IN IRAQI DYSLIPIDEMIA PATIENTS.
Dheyaa Aziz N; Abbood SH; Al-Mayali AH; Hadi NR
Pol Merkur Lekarski; 2023; 51(5):496-503. PubMed ID: 38069850
[TBL] [Abstract][Full Text] [Related]
17. Effect of SLCO1B1 gene polymorphisms and vitamin D on statin-induced myopathy.
Alghalyini B; El Shamieh S; Salami A; Visvikis Siest S; Fakhoury HM; Fakhoury R
Drug Metab Pers Ther; 2018 Mar; 33(1):41-47. PubMed ID: 29420305
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients.
Toms TE; Smith JP; Panoulas VF; Douglas KM; Saratzis AN; Kitas GD
Musculoskeletal Care; 2010 Mar; 8(1):2-9. PubMed ID: 19642078
[TBL] [Abstract][Full Text] [Related]
19. Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study.
Puccetti L; Ciani F; Auteri A
Atherosclerosis; 2010 Jul; 211(1):28-9. PubMed ID: 20347093
[No Abstract] [Full Text] [Related]
20. Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.
Lu B; Sun L; Seraydarian M; Hoffmann TJ; Medina MW; Risch N; Iribarren C; Krauss RM; Oni-Orisan A
Clin Pharmacol Ther; 2021 Sep; 110(3):733-740. PubMed ID: 34114646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
